Patient-focused Interactive Decision Support Tool

Share

Program Content

Activities

  • Expert Insights on HER2+ EBC
    Treatment Options From 5 Experts on Neoadjuvant and Adjuvant Therapy for HER2-Positive Early Breast Cancer: An Online Tool
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 19, 2019

    Expires: March 17, 2020

Faculty

cover img faculity

Frankie Ann Holmes, MD, FACP

Medical Oncologist
US Oncology/Texas Oncology
Houston, Texas

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Joyce O’Shaughnessy, MD

Co-Director, Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology
US Oncology
Dallas, Texas

cover img faculity

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

cover img faculity

Denise A. Yardley, MD

Senior Investigator
Breast Cancer Research Program
The Sarah Cannon Research Institute and Tennessee Oncology
Nashville, Tennessee

Provided by

ProCE Banner

Supporters

Genentech TEXT Only

Partners

GRACE

ProCE Banner